Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures.

The findings in our study support that alendronate is used for the primary and secondary prevention of GI fractures, but do not support that alendronate is recommended as a first-line agent for patients receiving a low dose of GCs or patients with PVF.